BAMCO Inc’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-954,547
Closed -$96.9M 337
2025
Q4
$96.9M Sell
954,547
-1,184,503
-55% -$95.1M 0.26% 71
2025
Q3
$117M Buy
2,139,050
+277,709
+15% +$13.9M 0.31% 61
2025
Q2
$98.9M Buy
1,861,341
+388,627
+26% +$19.7M 0.27% 77
2025
Q1
$63.8M Buy
1,472,714
+579,714
+65% +$29.4M 0.19% 105
2024
Q4
$50.2M Buy
893,000
+265,000
+42% +$16.5M 0.13% 135
2024
Q3
$42.8M Hold
628,000
0.11% 150
2024
Q2
$26.5M Buy
628,000
+618,000
+6,180% +$34M 0.08% 186
2024
Q1
$691K Sell
10,000
-21,000
-68% -$1.33M ﹤0.01% 316
2023
Q4
$2.29M Sell
31,000
-9,000
-23% -$590K 0.01% 287
2023
Q3
$2.73M Sell
40,000
-19,000
-32% -$1.61M 0.01% 281
2023
Q2
$5.54M Buy
59,000
+24,000
+69% +$1.87M 0.02% 258
2023
Q1
$2.37M Buy
+35,000
New +$2.25M 0.01% 295
2019
Q3
Sell
-800
Closed -$94K 358
2019
Q2
$94K Buy
+800
New +$80.6K ﹤0.01% 337

Other funds holding EXAS

BAMCO Inc's EXAS Position: Q1 2026 in Review

BAMCO Inc sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 954,547 shares — an estimated $96.9M sold.

BAMCO Inc first reported a position in EXAS in Q2 2019 and held it in 13 quarters. The position peaked at $117M in Q3 2025. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • BAMCO Inc reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • BAMCO Inc sold 954,547 Exact Sciences shares in Q1 2026, an estimated $96.9M.
  • BAMCO Inc first reported a position in Exact Sciences in Q2 2019 and held it in 13 quarters.
  • BAMCO Inc's Exact Sciences position peaked at $117M in Q3 2025.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on BAMCO Inc's 13F filing for Q1 2026, filed 15 May 2026.